KalshiOpen
Medtronic cardiovascular organic growth in fiscal 2027: Will Medtronic plc report Above 8% cardiovascular organic revenue growth in fiscal 2027?
Above 8%81%
No20%
Price checked at
Trade
Set your country to see where you can trade.Set your country →
Opens the venue in a new tab, through Predxy.24h volume$0
7d volume—
30d volume—
Liquidity—
Spread10%
ResolvesSep 30, 2027in 12 months
Probability history
Market-implied probabilities · All recorded historyDrag to move · pinch or ⌘/Ctrl+scroll to zoom
Shaded periods have no successful hourly price check.
Based on this market’s outcome prices, expressed as probabilities.
Resolution rules
If Medtronic plc reports Above 8% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes. This market refers to the annual figure reported in Medtronic plc's full fiscal year or Q4 earnings release. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.
Other legs of this event
A leg read alone is misleading; the others are beside it.Venue activity
Read from the venue this minuteHolders—
Held value—
Trades (24h)—
Trades—
Open interest—
Comments0
Discussion on Predxy
What Predxy's readers make of this market. Everyone can read; signed-in readers can write. The venue's own thread, when it has one, is the box below.Sign in to join the discussion.
Nobody has said anything here yet.
As of Sep 30, 10:54 PM UTC